CVS Health Corporation (CVS:NYSE) closed at $89.35 on November 13, 2026, down 0.49% on the day. The stock trades 19.3% below its 52-week high of $110.68 and 28.5% above its 52-week low of $69.51. Over the past year, it gained 14.8%. CVS Health Corporation is part of the Health Care sector (Medical/Nursing Services).
In 252 trading sessions since November 13, 2025, CVS closed higher on 125 days (50%). Its best day was May 6, 2026 (+7.65%) and its worst was January 27, 2026 (-14.15%). The stock moved 10% or more in a single session 2 times.
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, Medicare Part D plans, managed Medicaid plans, plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and ACS Pharmacy names. As of December 31, 2016, it had 23 retail specialty pharmacy stores, 13 specialty mail order pharmacies and 4 mail order dispensing pharmacies, and 84 branches for infusion and enteral services. T...
Find more stocks like CVS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.